Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]

Affiliations

• ¹ 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland. Electronic address: evita.fragou@gmail.com.
• ² Université de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: drifa.belhadi@aphp.fr.
• ³ Université de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: nathan.peiffer-smadja@inserm.fr.
• ⁴ 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. Electronic address: bmosxop@yahoo.gr.
• ⁵ Université de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: xavier.lescure@aphp.fr.
• ⁶ Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: hannah.Janocha@med.uni-giessen.de.
• ⁷ 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. Electronic address: manoskarofilakis@gmail.com.
• ⁸ Université de Paris, IAME, INSERM, F-75018, Paris, France; Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: yazdan.yazdanpanah@aphp.fr.
• ⁹ Université de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: france.mentre@inserm.fr.
• ¹⁰ European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: Chrysanthi.Skevaki@uk-gm.de.
• ¹¹ Université de Paris, IAME, INSERM, F-75018, Paris, France; Département d'Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat - Claude-Bernard, AP-HP, 75018, Paris, France. Electronic address: cedric.laouenan@inserm.fr.
• ¹² 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Switzerland. Electronic address: sotirios.tsiodras@gmail.com.